Clinical Trial Update: Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus [NA]

View source ↗

Summary

A terminated clinical trial evaluated the effect of Zegerid on esophageal pH in patients with Barrett's esophagus and gastroesophageal reflux disease; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Gastroesophageal Reflux Disease

Drugs mentioned

• Zegerid (omeprazole/sodium bicarbonate)

Snippet

Sponsor: Stanford University | Conditions: Barrett Esophagus, Gastroesophageal Reflux | NA | Status: TERMINATED | Results posted: 2017-06-06